We are very excited to announce that we have closed the two newest funds of the TCG fund family – The Column Group V (“TCG
The Column Group announces the hiring of Dr. Hui Tian. Previously, Dr. Tian was a founding member of NGM Biopharmaceuticals and most recently served as
The Column Group announces the promotion of Dr. Sarah Hymowitz from Venture Partner to Partner. Dr. Hymowitz has been with TCG since 2021.
The Column Group announces the hiring of Mr. Jeff Goater. Previously, Mr. Goater served as Chief Executive Officer of Surface Oncology. Prior to Surface, he
The Column Group announces the hiring of Dr. Sarah Gillmor Hymowitz. Previously, Dr. Hymowitz spent 22 years at Genentech rising to Vice President of Protein
Widely considered to be the father of the biotechnology industry, Robert Swanson changed the world when he founded Genentech with Herbert Boyer in 1976. TCG’s
The Column Group announced the recruitment of Dr. Eric Olson to the firm’s renowned group of Science Partners. Dr. Olson is the founding Chair of
The Column Group announces the hiring of Dr. John Josey. Previously, Dr. Josey served as the President, Chief Executive Officer and a member of the